Luxury beauty house Lancôme is ushering in a new era of skincare with the launch of Absolue Longevity MD – a dermatologist-validated range that integrates cutting-edge longevity science with advanced topical formulations.
As the global conversation around aging evolves, longevity is no longer defined simply by lifespan, but by health span, the quality of years lived in vitality, resilience, and strength. With increasing life expectancy, aging is now viewed less as an inevitable decline and more as a biological process that can be supported, optimized, and even influenced.
Within this shift, skincare is taking on a more profound role. Moving beyond aesthetics, the industry is beginning to address the visible biological mechanisms of aging reframing skin not just as a surface concern, but as a reflection of overall health.
With over 90 years of scientific heritage and backed by the research capabilities of the L’Oréal Groupe, Lancôme is positioning itself at the forefront of this transformation. Its proprietary Longevity Integrative Science™ approach focuses on targeting visible manifestations of aging while supporting long-term skin vitality, resilience, and renewal.
Rather than pursuing the traditional goal of “looking younger,” the brand’s latest innovation emphasizes maintaining confidence and vitality at every stage of life.
This forward-thinking direction is reinforced through strategic partnerships with biotech leaders, including Swiss company Timeline® and Korean beauty tech startup NanoEntek™, enabling Lancôme to bridge advanced biotechnology with high-performance skincare.
Absolue Longevity MD: From Supplement Science to Skincare
At the core of the new Absolue Longevity MD range is Mitopure® – Timeline’s proprietary Urolithin-A, widely regarded as the #1 selling longevity supplement ingredient. Backed by over $50 million in research and 15 years of scientific development, Mitopure® is now being introduced into skincare on a global scale for the first time.
Central to longevity science is mitochondrial health. As the energy generators of cells, mitochondria play a key role in skin renewal and resilience. Over time, their efficiency declines, contributing to visible aging signs. By incorporating Mitopure® into topical formulas, Lancôme translates this biological insight into high-performance skincare designed to support skin’s energy and renewal processes.
The Absolue Longevity MD line has been validated in partnership with an advisory board of dermatologists, ensuring rigorous testing protocols, ingredient safety, and proven efficacy.
A Three-Stage Approach to Skin’s Biological Aging
Recognizing that skin evolves over time, Lancôme has structured the range around three targeted intervention models: Anticipate, Intercept, and Reset. Each addresses different stages of visible biological aging, offering both proactive and corrective solutions.
Anticipate (Biological Age: Under 35)
Designed to act before visible signs appear, the Anticipate model focuses on prevention. Its proprietary compound combines Mitopure® (98.5% pure, micronized Urolithin-A) with Epigenomyl®, Eperuline, Ectoin, Rose Pro-Xylane, and Taurine.
Clinical results show:
- A 16% reduction in the appearance of incoming fine lines after three months
- Up to 50% reduction in skin oxidation with daily use
This stage aims to fortify skin’s youthful appearance before aging markers become visible.
Intercept (Biological Age: 35–55)
Targeting signs as they emerge, the Intercept compound blends Mitopure® with LHA, Matrixyl™, Niacinamide, Rose Pro-Xylane, and Taurine.
Clinical findings include:
- Up to 76% improvement in skin elasticity within four hours
- Up to 4 million new surface cells generated daily after three weeks
This phase focuses on maintaining luminosity and firmness as aging signs begin to surface.
Reset (Biological Age: Over 55)
For more mature skin, the Reset model addresses visible signs that have already developed. Its formulation combines Mitopure® with Senevisium®, Rhamnose, Niacinamide, Rose Pro-Xylane, and Taurine.
Results show:
- A 55% increase in skin bounce after four hours
- 15% faster surface cell renewal over three weeks
The goal is to restore vitality and improve the appearance of skin that shows more advanced signs of aging.
With Absolue Longevity MD, Lancôme is not only introducing a new product line, but also redefining the role of skincare within the broader longevity movement. By merging biotechnology, dermatological validation, and luxury formulation, the brand sets a new benchmark for how beauty can support skin across its entire lifespan.
The Absolue Longevity MD range will be available starting April 20 on lancome-usa.com, followed by a nationwide rollout at select luxury retailers on May 1.